Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)

Clinical trial NCT02380235 · UNKNOWN

Trial details

NCT number: NCT02380235
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Growth Hormone Deficiency

Start date: 2014-12-01
Primary completion: 2017-06-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.